METHOTREXATE
Substance profile for UNII YL5FZ2Y5U1, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 126941Substance Identity#
- UNII
- YL5FZ2Y5U1
- Preferred term
- METHOTREXATE
- Registry number
- 59-05-2
- EC number
- 200-413-8
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C20H22N8O5
Structure render from PubChem CID 126941Chemical And Database Identifiers#
- InChIKey
- FBOZXECLQNJBKD-ZDUSSCGKSA-N
- SMILES
- CN(CC1=NC2=C(N)N=C(N)N=C2N=C1)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
- RxCUI
- 6851
- PubChem
- 126941
- NCIt
- C642
- INN ID
- 926
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.] | 11 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE SODIUM TABLET [ROXANE LABORATORIES, INC] | 8 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE TABLET [MYLAN PHARMACEUTICALS INC.] | 6 | |
| METHOTREXATE | ACTIVE INGREDIENT | YL5FZ2Y5U1 | METHOTREXATE TABLET [MYLAN PHARMACEUTICALS INC.] | 6 | |
| Methotrexate | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE SODIUM INJECTION, SOLUTION [SANDOZ INC] | 5 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE TABLET [MYLAN INSTITUTIONAL INC.] | 5 | |
| METHOTREXATE | ACTIVE INGREDIENT | YL5FZ2Y5U1 | METHOTREXATE TABLET [MYLAN INSTITUTIONAL INC.] | 5 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE SODIUM TABLET [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE TABLET [BARR LABORATORIES INC.] | 4 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE TABLET [PD-RX PHARMACEUTICALS, INC.] | 4 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 3 | |
| METHOTREXATE | ACTIVE INGREDIENT | YL5FZ2Y5U1 | OTREXUP (METHOTREXATE) INJECTION, SOLUTION [ANTARES PHARMA, INC.] | 3 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | OTREXUP (METHOTREXATE) INJECTION, SOLUTION [ANTARES PHARMA, INC.] | 3 | |
| methotrexate | ACTIVE MOIETY | YL5FZ2Y5U1 | RASUVO (METHOTREXATE) INJECTION, SOLUTION [MEDAC PHARMA, INC] | 3 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | TREXALL (METHOTREXATE) TABLET, FILM COATED [TEVA WOMEN'S HEALTH, INC.] | 3 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 2 | |
| methotrexate | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE (METHOTREXATE SODIUM) TABLET [REBEL DISTRIBUTORS CORP] | 2 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE INJECTION [MYLAN INSTITUTIONAL LLC ] | 2 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE INJECTION [MYLAN INSTITUTIONAL LLC ] | 2 | |
| METHOTREXATE | ACTIVE INGREDIENT | YL5FZ2Y5U1 | METHOTREXATE INJECTION [MYLAN INSTITUTIONAL LLC ] | 2 | |
| METHOTREXATE | ACTIVE INGREDIENT | YL5FZ2Y5U1 | METHOTREXATE INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC] | 2 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC] | 2 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE SODIUM TABLET [BRYANT RANCH PREPACK] | 2 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE TABLET [DAVA PHARMACEUTICALS, INC.] | 2 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE TABLET [MAJOR PHARMACEUTICALS] | 2 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | RHEUMATREX DOSE PACK (METHOTREXATE) TABLET [DAVA PHARMACEUTICALS, INC.] | 2 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE (METHOTREXATE) TABLET [AVKARE, INC.] | 1 | |
| METHOTREXATE | ACTIVE INGREDIENT | YL5FZ2Y5U1 | METHOTREXATE INJECTION [ACCORD HEALTHCARE, INC.] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE INJECTION [ACCORD HEALTHCARE, INC.] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.] | 1 | |
| METHOTREXATE | ACTIVE INGREDIENT | YL5FZ2Y5U1 | METHOTREXATE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.] | 1 | |
| METHOTREXATE | ACTIVE INGREDIENT | YL5FZ2Y5U1 | METHOTREXATE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.] | 1 | |
| METHOTREXATE | ACTIVE INGREDIENT | YL5FZ2Y5U1 | METHOTREXATE INJECTION, SOLUTION [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE INJECTION, SOLUTION [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE SODIUM INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC ] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE SODIUM INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC.] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE SODIUM TABLET [GENPAK SOLUTIONS LLC] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE SODIUM TABLET [REMEDYREPACK INC. ] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE SODIUM TABLET [REMEDYREPACK INC. ] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE TABLET [PD-RX PHARMACEUTICALS, INC.] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE TABLET [REMEDYREPACK INC. ] | 1 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | METHOTREXATE TABLET [REMEDYREPACK INC. ] | 1 | |